JorgeDiMartinoMDPh.D.
Pediatric Hematology & Oncology • Palo Alto, CAAdjunct Clinical Assistant Professor
Dr. DiMartino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-723-5535- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1996 - 1999- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1993 - 1996
University of California San Diego School of MedicineClass of 1994
Cornell University Graduate School of Medical SciencesPh.D., 1988 - 1992
Certifications & Licensure
CA State Medical License 1994 - 2024
OH State Medical License 2004 - 2007
Publications & Presentations
PubMed
- 41 citationsMultiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome.Kevin Leung, Aaron N. Nguyen, Tao Shi, Lin Tang, Xiaochun Ni, Laure Escoubet, Kyle J. MacBeth, Jorge DiMartino, James A. Wells> ;Proceedings of the National Academy of Sciences of the United States of America. 2019 Jan 8
- The DOT1L Inhibitor Pinometostat Reduces H3K79 Methylation and Has Modest Clinical Activity in Adult Acute LeukemiaEytan M Stein, David A Rizzieri, Raoul Tibes, Martin S Tallman, Jesus G Berdeja, Jorge DiMartino, Michael R Savona, Jessica K Altman, Scott A Armstrong> ;Blood.
- 247 citationsMicroenvironment Determines Lineage Fate in a Human Model of MLL-AF9 LeukemiaJunping Wei, Mark Wunderlich, Catherine Fox, Sara Alvarez, Juan C. Cigudosa, Jamie Wilhelm, Yi Zheng, Jose A. Cancelas, Yi Gu, Michael Jansen, Jorge F. DiMartino, Jame...> ;Cancer Cell. 2008 Jun 10
- Join now to see all
Press Mentions
- Kronos Bio Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Lanraplenib in Combination with Gilteritinib in Acute Myeloid LeukemiaAugust 22nd, 2022
- Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AMLAugust 17th, 2022
- Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical DevelopmentFebruary 1st, 2022
- Join now to see all
Hospital Affiliations
Lucile Packard Children's Hospital StanfordPalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
